Heart Failure with Preserved Ejection Fraction
📧 Sign up to get email alerts when something new happens for Heart Failure with Preserved Ejection Fraction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Triple Combination Therapy (ARNI, SGLT2i, MRA) in Advanced HFpEF [Phase 2]
A Phase 2 trial is evaluating a triple therapy comprising an ARNI, an SGLT2 inhibitor, and a mineralocorticoid receptor antagonist for advan…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Novel Approaches for Improving Vascular Function in Veterans With HFpEF [Phase 1]
A Phase 1 trial in veterans with heart failure with preserved ejection fraction (HFpEF) and inflammation is exploring novel approaches to im…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study of LY3971297 in Participants With Heart Failure [Phase 1]
Phase 1 study of LY3971297 in participants with heart failure (including diastolic and systolic subtypes) is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Selenium Intervention Registry Randomized Trial in Heart Failure [Phase 3]
A Phase 3 randomized trial evaluating selenium supplementation in patients with various forms of heart failure is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Muscle Blood Flow Regulation in HFpEF [NA]
A recruiting clinical trial is studying muscle blood flow regulation in heart failure with preserved ejection fraction.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: OBESE-HFpEF: Towards Preventing Obesity Related HFpEF
This is a clinical trial update for OBESE-HFpEF, a study aimed at preventing obesity-related heart failure with preserved ejection fraction.…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Exercise Cardiovascular Magnetic Resonance In Heart Failure With Preserved Ejection Fraction
A Mayo Clinic-sponsored study is recruiting to examine exercise cardiovascular magnetic resonance imaging in people with heart failure with …
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Predictors of Poor Prognosis in HFpEF
This clinical trial investigates predictors of poor prognosis in heart failure with preserved ejection fraction (HFpEF) and is currently rec…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Physical Activity, Cardiac and Skeletal Muscle Energetics in Healthy Subjects and HFpEF Patients
A clinical trial update from Johns Hopkins on physical activity and energetic function in healthy individuals and patients with heart failur…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: SGLT2i and KNO3 in HFpEF - The SAK HFpEF Trial [Phase 2]
A Phase 2 clinical trial sponsored by the University of Pennsylvania is evaluating an SGLT2 inhibitor in combination with potassium nitrate …
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Exercise Testing After Preeclampsia
The document reports that a Vanderbilt University Medical Center study evaluating exercise testing after preeclampsia is currently recruitin…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: AI-based Echocardiography for Detection of Cardiac Amyloidosis [NA]
An AI-based echocardiography study aimed at detecting cardiac amyloidosis; the trial status is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease [Phase 1, Phase 2]
A Phase 1/2 clinical trial sponsored by Northwestern University is evaluating the effects of dapagliflozin on metabolomics and cardiac mecha…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Targets
A clinical trial named HeartShare aims to integrate omics data, deep phenotyping, and electronic health records to define heart failure subt…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: PCI With Guideline-Directed Medical Therapy for HFpEF Patients With Ischemic Cardiomyopathy [NA]
An upcoming clinical trial is evaluating percutaneous coronary intervention with guideline-directed medical therapy for patients with heart …
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction
Northwestern University-led clinical trial investigating myocardial mechanisms in heart failure with preserved ejection fraction is currentl…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) [Phase 1]
Phase 1 trial evaluating the safety, tolerability, and biomarker signals of VS-041 in participants with heart failure with preserved ejectio…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: PREACTIVE: Preconditioning Exercise Intervention to Improve Symptoms and Quality of Life in Comorbid Atrial Fibrillation and HFpEF [NA]
This clinical trial update describes PREACTIVE, a study evaluating a preconditioning exercise program to improve symptoms and quality of lif…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: SGLT2 Inhibitors, Ketones, and Cardiovascular Benefit Research Plan [EARLY_Phase 1]
This early-phase trial plan explores the cardiovascular benefits of SGLT2 inhibitors and ketone strategies in people with type 2 diabetes an…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety in Concomitant Administration of Macitentan and Dapagliflozin in Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction (HFmrEF and HFpEF) and Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) [Phase 4]
Phase 4 trial evaluating concomitant administration of macitentan and dapagliflozin in patients with heart failure with mid-range and preser…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Determination of the Prevalence of Unrecognized Heart Failure Among Patients at Risk in Urban Areas Across Germany Using CMR
This registry entry describes a German clinical study to determine how common unrecognized heart failure is among at-risk urban patients usi…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Pharmacological Optimization in Prevention in Heart Failure: A Sex-gap? [Phase 4]
An update on a Phase 4 trial evaluating pharmacological optimization to prevent heart failure, including consideration of sex differences; r…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: ELEVATE-HFpEF Clinical Study [NA]
Clinical trial update for ELEVATE-HFpEF studying a therapy for heart failure with preserved ejection fraction; the study is currently recrui…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study) [Phase 2]
Phase 2 clinical trial APEX is evaluating TX000045 for pulmonary hypertension secondary to heart failure with preserved ejection fraction an…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: PBMC as Biomarkers of Diabetic Cardiomyopathy
A clinical trial is evaluating peripheral blood mononuclear cells as biomarkers for diabetic cardiomyopathy and related heart failure condit…